GMH Organics

What GMH Organics does

GMH Organics is an Indian pharmaceutical company established in 2005, headquartered in Baddi, Solan district (Himachal Pradesh), operating as a B2B contract manufacturer of sterile dry powder injectable antibiotics. The company's core production is concentrated in the beta-lactam antibiotic group across three product families: Cephalosporins, Penicillins, and Carbapenems, with 50+ product formulations and an annual production capacity of 50 million dosages across two co-located manufacturing units. Its facilities hold WHO GMP and EU GMP certifications, and production is supported by 41 air handling units with dehumidification and air filtration systems, enabling export-grade quality for international pharmaceutical clients.

The company's service offering spans the full contract manufacturing value chain: new formulation development, Fixed Dose Combination (FDC) innovation, bioequivalence studies, clinical trials, DCGI regulatory approval, and commercial production under customer brand names. It serves both domestic Indian pharmaceutical companies and international clients in 40+ countries across South Asia, Sub-Saharan Africa, LATAM, EMEA, and Southeast Asia, with a reported customer base of 350+ enterprises. Pricing is negotiated on a contract-by-contract basis, with multi-year enterprise contracts, and the company is described as zero-debt and self-funded. GMH also partners with unnamed academic and research institutions to support regulatory documentation and research publication requirements. The company employs approximately 250 people, markets primarily through a corporate website, LinkedIn, and YouTube, and presents itself as a specialized, quality-certified contract manufacturing partner for pharmaceutical companies seeking cost-effective sterile injectable production capacity.

Name

GMH Organics

Legal name

GMH Organics

Website

https://gmh.co.in

Company type

Private

Founded year

2005

Operating status

Operating

Headcount range

101–250 employees

Short description

GMH Organics is an Indian B2B contract manufacturer of sterile dry powder injectable beta-lactam antibiotics, producing 50+ formulations across Cephalosporins, Penicillins, and Carbapenems for 350+ pharmaceutical clients in 40+ countries.

Ownership category

akta.pro rank

Product category

Pharmaceutical Contract Manufacturing

NAICS

Pharmaceutical Preparation Manufacturing (325412)

SIC

Biological Products, (No Disgnostic Substances) (2836)

akta.pro primary industry

GMP Quality, Validation & Regulatory Support (GMP/CSV/Qualification) (HLAGAGAL)

Keywords

• Pharmaceutical contract manufacturing
• Sterile injectables production
• Beta-lactam antibiotics manufacturing
• Dry powder injectables
• Generic drug formulation

Headquarters

HQ city

Solan

HQ country

India

HQ region

Asia

Offices3 records

Markets served

GTM type

B2B

Offering type

Hardware or Manufacturing

Cost components

Operations, Supply Chain, Personnel, Infrastructure, Technology or R&D, Marketing or Sales

Revenue model

1. Contract Manufacturing Services: Contract manufacturing of pharmaceutical products including formulation development, bioequivalence studies, clinical trials, regulatory approvals, and manufacturing under customer brand names for both domestic and export markets

Pricing tiers

Go-to-market motion1 record

Distribution channels2 records

Marketing channels3 records

Core offering

GMH Organics is a B2B pharmaceutical contract manufacturer specializing in sterile dry powder injectables in the beta-lactam antibiotic group (Cephalosporins, Penicillins, and Carbapenems). The company offers end-to-end services including formulation development, bioequivalence studies, clinical trials, DCGI regulatory approval, and large-scale manufacturing of antibiotic injectables under customer brand names for both domestic Indian and 40+ export markets.

Product overview

GMH Organics is a pharmaceutical company specializing in sterile antibiotics, specifically small volume parenterals in the dry powder injectable beta lactam group. The company operates as a contract manufacturer producing three main product categories: Cephalosporin, Penicillin, and Carbapenem antibiotics. These products are manufactured under WHO GMP and EU GMP certified facilities and are exported to 40 countries under customer brand names. The company develops new formulations, undertakes bioequivalence studies and clinical trials, and obtains DCGI approval for manufacturing and marketing of new Fixed Dose Combinations (FDCs) and molecules.

Differentiator

Problem solved

Functional benefit

Products and services

• Cephalosporin Injectables A class of beta-lactam antibiotics manufactured as sterile dry powder injectables, including Ceftriaxone, Cefotaxime, Ceftazidime, Cefepime, Cefoperazone, and various sulbactam/tazobactam combinations at multiple dosage strengths ranging from 187.5mg to 2000mg. Manufactured under contract for pharmaceutical companies for domestic Indian market and export to 40+ countries.
• Penicillin Injectables A class of beta-lactam antibiotics manufactured as sterile dry powder injectables, including Piperacillin Tazobactam, Amoxycillin Potassium Clavulanate, Ampicillin, Ampicillin Sulbactam, and Ticarcillin Clavulanic acid at various dosage strengths. Manufactured as a contract manufacturing offering for pharmaceutical companies under WHO GMP and EU GMP certified facilities.
• Carbapenem Injectables A class of broad-spectrum beta-lactam antibiotics manufactured as sterile dry powder injectables, including Meropenem (multiple strengths), Meropenem EDTA, Imipenem & Cilastatin, Meropenem Sulbactam, Doripenem, and Aztreonam. Produced as a contract manufacturing service for pharmaceutical distribution companies.

Named customers1 record

Segments2 records

Ideal customer profiles1 record

Technology focussed No

API detail

Has API

No

API docs

API detail

Core technology

AI maturity

App detail

Feature1 record

Partnerships

One partnership is on record.

• Academic and Research Institutions (unnamed)coreStrategic or Co-development PartnerGMH has partnered with various academic and research institutions to incorporate services akin to meticulous documentation and research publications necessary for the pharmaceutical industry. These partnerships assist in documenting research and findings comprehensively for regulatory submissions and product development.

Scale indicators5 records

Recent moves5 records

Expansion highlights4 records

Broad incumbents

• Lupin Pharmaceuticals: Major Indian pharmaceutical company with cephalosporin and penicillin manufacturing capabilities across dosage forms including injectables. Comparable as an Indian-headquartered beta-lactam manufacturer, though substantially larger and with branded generics presence GMH lacks.
• Aurobindo Pharma: Large Indian pharmaceutical company with a significant sterile injectable (cephalosporin) manufacturing footprint and global export reach across 150+ countries. Comparable as an Indian-headquartered producer of beta-lactam injectables serving global markets, though materially larger and more diversified than GMH.
• Cipla: One of India's largest pharmaceutical companies with a meaningful presence in anti-infectives including injectable antibiotics and global export operations. Comparable as an Indian anti-infective manufacturer but with much broader therapeutic scope and stronger brand equity.

Regional players

• Alkem Laboratories: Indian pharmaceutical manufacturer with a domestic and export business across anti-infectives, including injectable formulations. Comparable in Indian origin, beta-lactam category presence, and export orientation, though more diversified into oral dosage forms.

Direct peers

• Strides Pharma Science: Indian pharmaceutical company specializing in generic formulations including sterile injectables, with significant contract development and manufacturing operations. Comparable target market (regulated and emerging market pharma buyers), manufacturing profile (sterile injectables), and B2B CDMO orientation.
• ACS Dobfar / FIMECS (Italian cluster): Italian-headquartered CDMO specializing in sterile cephalosporin and beta-lactam injectable manufacturing. Most direct beta-lactam product specialization overlap with GMH, though operating in EU regulatory environment rather than Indian domestic/exports.
• Hetero Labs: Indian pharmaceutical manufacturer with a strong focus on sterile injectables including beta-lactam antibiotics and a notable contract manufacturing arm. Directly comparable in product category (sterile dry powder injectables), geography of origin, and B2B contract manufacturing model.

Emerging players

• Jiangsu Hengrui Pharmaceuticals: Chinese-headquartered manufacturer with growing injectable antibiotic capacity and contract manufacturing services. Comparable as an Asia-headquartered sterile injectable CDMO targeting global markets, representing a competitive threat from a neighboring manufacturing hub.
• AstraZeneca (injectables portfolio): Global pharma major with growing outsourced manufacturing partnerships, particularly for sterile injectable anti-infectives in emerging markets. Comparable as a customer-side counterpart and as a benchmark for the kind of CDMO relationships GMH could pursue at scale.

Others

• ACS Dobfar (Antibióticos de México / Dobfar): Specialized beta-lactam (cephalosporin and penicillin) sterile injectable manufacturer with operations in Italy, Brazil, and Mexico serving global markets. Comparable as a dedicated beta-lactam injectable producer focused on contract manufacturing and B2B supply.

Market position

Strengths5 records

Weaknesses5 records

Competitive moat4 records

Key risks6 records

Key highlights7 records

Customer concentration

• YouTubeyoutube.com/channel/UC-Io8sigMC63Z5fSwdO_b_Q
• LinkedInlinkedin.com/company/gmh-organics
• Facebookfacebook.com/GMH-Organics-100063709281025

Compliance2 records

Revenue estimate

Valuation estimate

Number of profiles

Profiles4 records

Funding overview

Funding rounds

Investors

Funding detail is available on the Subscription and Enterprise plan.Contact sales →

M&A

Investments

M&A and investment is available on the Subscription and Enterprise plan.Contact sales →

Frequently asked questions about GMH Organics